Canadian Medical Center Co. (CMCER), which operates medical centers and executes medical clinic project contracts, reported a net profit of SAR 11.8 million for the first nine months of 2025, compared to SAR 5.8 million in the same period of 2024.
| Item | 9m 2024 | 9m 2025 | Change |
|---|---|---|---|
| Revenues | 80.44 | 104.03 | 29.3 % |
| Gross Income | 18.68 | 29.77 | 59.4 % |
| Operating Income | 6.66 | 15.25 | 128.8 % |
| Net Income | 5.80 | 11.76 | 102.7 % |
| Average Shares | 77.00 | 77.00 | - |
| Earnings Per Share before unusual items (Riyals) | 0.08 | 0.20 | 167.4 % |
| EPS (Riyal) | 0.08 | 0.15 | 102.7 % |
The company attributed higher profit to a 29.32% rise in revenues, driven by the company’s expansion across multiple segments, including construction, petrochemicals, mining, events, and ambulance transport, and signing new operation contracts in various regions across the Kingdom. This expansion contributed to diversifying income sources and supporting sustainable growth under the company’s transformation and expansion strategy.
CMCER witnessed improved operating margins, along with the implementation of more efficient financial and operational policies as part of the transformation plan.
On the other hand, the 9M 2025 included one-off costs related to the company’s transition to Tadawul’s TASI, in addition to losses from the investment portfolio.
| Item | Q3 2024 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 29.22 | 41.69 | 42.7 % |
| Gross Income | 7.17 | 12.61 | 76.1 % |
| Operating Income | 2.79 | 6.55 | 135.2 % |
| Net Income | 2.43 | 3.48 | 43.2 % |
| Average Shares | 77.00 | 77.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.03 | 0.10 | 205.2 % |
| EPS (Riyal) | 0.03 | 0.05 | 43.2 % |
| Item | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 32.25 | 41.69 | 29.3 % |
| Gross Income | 8.31 | 12.61 | 51.7 % |
| Operating Income | 3.51 | 6.55 | 86.7 % |
| Net Income | 0.83 | 3.48 | 319.1 % |
| Average Shares | 77.00 | 77.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.02 | 0.10 | 355.1 % |
| EPS (Riyal) | 0.01 | 0.05 | 319.1 % |
Q3 2025 net profit rose 43.2% year-on-year (YoY) to SAR 3.48 million from SAR 2.43 million.
On a sequential basis, net profit soared 319.1% from SAR 0.83 million in Q2 2025.
Shareholders’ equity, no minority interest, reached SAR 97.17 million by Sept. 30, 2025, compared to SAR 90.08 million in a year earlier period.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website

Comments Analysis: